Variant report
Variant | nsv521751 |
---|---|
Chromosome Location | chr20:23324651-23325047 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2066451 | chr20:23324651-23324652 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs555773237 | chr20:23324675-23324676 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78279601 | chr20:23324678-23324679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143747714 | chr20:23324679-23324680 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569823202 | chr20:23324729-23324730 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188742059 | chr20:23324732-23324733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548949153 | chr20:23324782-23324783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192579776 | chr20:23324810-23324811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7345891 | chr20:23324814-23324815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185019636 | chr20:23324851-23324852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544644252 | chr20:23324868-23324869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557719832 | chr20:23324875-23324876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571170768 | chr20:23324900-23324901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537319677 | chr20:23324908-23324909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562984897 | chr20:23324909-23324910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372042391 | chr20:23324925-23324926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148144117 | chr20:23324959-23324960 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73901808 | chr20:23325001-23325002 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs141998832 | chr20:23325012-23325013 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6048740 | chr20:23325047-23325048 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17133270 | CNVD |
Thrombophilia | 17576883 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:23321800-23329400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
2 | chr20:23324600-23325400 | Enhancers | HepG2 | liver |
3 | chr20:23324600-23326000 | Enhancers | Fetal Heart | heart |
4 | chr20:23324800-23325600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
5 | chr20:23324800-23326000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr20:23325000-23325200 | Enhancers | Placenta Amnion | Placenta Amnion |
7 | chr20:23325000-23326800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |